DNDI-6510

CAT: 0804-HY-176264Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-176264Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DNDI-6510 (Compound (S) -x38) is a non-covalent SARS-CoV-2 MPro inhibitor with a IC50 of 0.04 μM. DNDI-6510 has a potent antiviral activity across SARS-CoV-2 and its variants as well as a weak efficacy to SARS-CoV-1. DNDI-6510 significantly improves drug exposure in metabolically humanized mice model (8HUM) [1].
UNSPSC
12352005
Target
Cytochrome P450; SARS-CoV; Virus Protease
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Field of Research
Infection
Smiles
CNC(C1(CC1)N2C[C@@]3(C4=C(C2=O)C=CC(Cl)=C4)CCN(C3=O)C5=C6C=CC=CC6=CN=C5)=O
Molecular Formula
C26H23ClN4O3
Molecular Weight
474.94
References & Citations
[1]Griffen E J, et al. Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor[J]. bioRxiv, 2025: 2025.06. 16.660018.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP2; CYP3

Related Products

CatalogName
HY-139854-01DNDI-6148
HY-124623DNDI-8219
HY-156132DNDI-0690
HY-162066-01DNDI-6174
HY-129819(Rac) -DNDI-8219
HY-R01947-01Hsa-miR-6510-3p mimic
HY-RI01947A-01Hsa-miR-6510-3p antagomir
HY-RI01948-01Hsa-miR-6510-5p inhibitor
HY-R01948-01Hsa-miR-6510-5p mimic
HY-R01947A-01Hsa-miR-6510-3p agomir

Alternative Products

CatalogName
T210581-01DNDI-6510
T39746-01DNDI-6148
BA2117-5DNDI-6174
MBS5773769DNDI-8219
MPH03422hsa-miR-6510-5p Primers
MPH03421hsa-miR-6510-3p Primers
MBS8312701-01hsa-miR-6510-3p miRNA Agomir
mh42283LentimiRa-hsa-miR-6510-3p Vector
CIH2006-01Hsa-miR-6510-3p miRNA Inhibitor
mh2284AdmiRa-hsa-miR-6510-5p Virus

Popular Products